• Corpus ID: 24759841

Hypocholesterolemic effects of nicotinic acid and chromium supplementation.

  title={Hypocholesterolemic effects of nicotinic acid and chromium supplementation.},
  author={M. M. Urberg and J Benyi and Racheal Ezinne John},
  journal={The Journal of family practice},
  volume={27 6},
During the course of a study of the hypoglycemic effects of nicotinic acid and chromium on humans, two hypercholesterolemic subjects were found to experience clinically significant decreases in serum cholesterol levels. These subjects have now been followed for one year. The first subject had a cholesterol level of 10.33 mmol/L (399 mg/dL). Daily supplementation for four weeks with 100 mg of nicotinic acid (niacin) and 200 micrograms of chromium chloride led to a decrease in serum cholesterol… 

Beneficial effects of combined treatment with niacin and chromium on the liver of hyperlipemic rats

Serum total lipid and cholesterol levels were determined by spectrophotometric methods and niacin decreases total plasma levels of cholesterol, triglycerides, and low-density cholesterol and increases high-density lipoprotein cholesterol.

Combined treatment with niacin and chromium caused a protective effect on the small-intestine tissue of hyperlipidemic rats

Niacin and chromium treatments had a protective effect on the intestine of the hyperlipidemic rats as well as a lipid-reducing effect.

Chromium as an essential nutrient for humans.

  • R. Anderson
  • Medicine
    Regulatory toxicology and pharmacology : RTP
  • 1997
Chromium is an essential nutrient required for sugar and fat metabolism and given to people with impaired glucose tolerance or diabetes leads to improved blood glucose, insulin, and lipid variables as well as improving lean body mass in humans and swine.

Chromium in the elderly

The data suggest that Cr retention may decrease with aging and that aging may alter Cr metabolism, and diets of many healthy elderly people may be insufficient during the stresses and illnesses associated with aging.

Cholesterol efflux and the effect of combined treatment with niacin and chromium on aorta of hyperlipidemic rat

Combined treatment with niacin and chromium prevents the morphological and biochemical changes observed in thoracic aorta of hyperlipidemic rats, and may regulate effectively cardiovascular diseases inducing an increase in StAR levels on endothelial cells.

Chromium, glucose intolerance and diabetes.

  • R. Anderson
  • Medicine, Biology
    Journal of the American College of Nutrition
  • 1998
Within the last 5 years chromium (Cr) has been shown to play a role in glucose intolerance, Type 2 diabetes mellitus (Type 2 DM), and gestational diabetes. In addition, diabetes and the neuropathy of

Benefits of chromium(III) complexes in animal and human health

Serum chromium does not predict glucose tolerance in late pregnancy.

Plasma chromium during pregnancy does not correlate with glucose intolerance, insulin resistance, or serum lipids, and may not accurately reflect tissue stores of chromium.

Introduction: A history of chromium studies (1955–2007)